CastleKnight Management »

Silverback Therapeutics shares owned by CastleKnight Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by CastleKnight Management from 13F filings

Historical chart of CastleKnight Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by CastleKnight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by CastleKnight Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $656k 65k 10.05
2025-06-30 $1.1M 65k 17.45
2025-03-31 $822k 65k 12.58

More positions owned by CastleKnight Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Micron Technology (MU)
Vertiv Holdings Com Cl A (VRT)
Marvell Technology (MRVL)
Modine Manufacturing Call Option (MOD)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A (GOOGL)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Tenet Healthcare Corp Com New (THC)
Teekay Tankers Cl A (TNK)
Hut 8 Corp (HUT)
Community Health Systems (CYH)

View all positions for CastleKnight Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics